immunotherapy

Health Innovators – Jo Brewer, Adaptimmune

https://pharmaphorum.com/video/health-innovators-jo-brewer-adaptimmune/

Deep Dive: Oncology 2021

https://pharmaphorum.com/views-analysis-oncology/deep-dive-oncology-2021/

Changing focus to cachexia may be key to improved cancer outcomes

https://pharmaphorum.com/views-analysis-oncology/changing-focus-to-cachexia-may-be-key-to-improved-cancer-outcomes/

The next generation of immunotherapy? Innate Pharma targets NK cells

https://pharmaphorum.com/views-and-analysis/the-next-generation-of-immunotherapy-innate-pharma/

Triple Negative Breast Cancer Drug Development Digital Summit

https://pharmaphorum.com/events/triple-negative-breast-cancer-drug-development-digital-summit/

Pfizer deal paves way for approval of ImaginAb’s cancer imaging tech

https://pharmaphorum.com/news/pfizer-deal-could-help-approval-of-imaginabs-cancer-imaging-tech/

2020 in review: Pharma’s progress outside of COVID-19

https://pharmaphorum.com/views-analysis-oncology/2020-review-pharmas-progress-outside-of-covid-19/

Cytokine-Based Cancer Immunotherapies Summit

https://pharmaphorum.com/events/cytokine-based-cancer-immunotherapies-summit/

Jounce shares crash after it abandons immunotherapy combination trial

https://pharmaphorum.com/news/jounce-shares-crash-after-it-abandons-immunotherapy-combination-trial/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search